The 2 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 6.38, with a high estimate of 7.75 and a low estimate of 5.00. The median estimate represents a +322.19% increase from the last price of 1.51.
The current consensus among 2 polled investment analysts is to Buy stock in Atossa Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.05
Reporting Date May 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.